Lars Ekman, M.D., Ph.D.

  • Executive Partner at Sofinnova Ventures
  • Over 28 years in senior executive, scientific, and clinical functions
  • Over 8 NDAs filed
  • Former President of R&D at Elan, EVP, R&D at Schwarz Pharma AG, and a variety of senior scientific and clinical functions at Pharmacia, now Pfizer

Eric Ostertag, M.D., Ph.D.

  • Poseida Chief Executive Officer

Nishan de Silva, M.D.

  • Poseida President and Chief Operating Officer

Robert Lyons

  • Over 25 years of experience in financial services industry
  • Serves on number of public and private company boards including Academy Securities and Medley Capital Corporation
  • Former Senior Managing Director Fixed Income Division at Knight Capital Group
  • Previously served more than 15 years at Merrill Lynch & Co., Inc. most recently as Former Vice Chairman, Investment Banking Division and Head of Global Capital Markets

Adrian Howd, Ph.D.

  • Chief Investment Officer at Malin Corporation plc
  • Previously with Berenberg, Nomura and ABN Amro where he was Global Head of Healthcare Research
  • Also previously Executive Vice President, Head of Neuroscience and Corporate Development at Evotec AG
  • Ph.D. in molecular neuroscience from the University of London and is a principal, director and shareholder of Brandon Point Industries